References
- Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95–99. doi:https://doi.org/10.1016/j.phrs.2017.11.003.
- Joyner MJ, Limberg JK. Blood pressure regulation: every adaptation is an integration? Eur J Appl Physiol. 2014;114(3):445–50. doi:https://doi.org/10.1007/s00421-013-2636-5.
- Hartupee J, Mann DL. Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol. 2017;14(1):30–38. doi:https://doi.org/10.1038/nrcardio.2016.163.
- Xing B, Cao A, Sun W, Hou X. Relationship between left ventricular diastolic dyssynchrony and systolic dyssynchrony in hypertrophic cardiomyopathy by single-cardiac real-time three-dimensional ultrasonography. Exp Ther Med. 2018;15(4):3769–74.
- Ancona R, Comenale Pinto S, Caso P, D’Andrea A, Di Salvo G, Arenga F, Coppola MG, Sellitto V, Macrino M, Calabrò R. Left atrium by echocardiography in clinical practice: from conventional methods to new echocardiographic techniques. ScientificWorldJournal. 2014;2014:451042. doi:https://doi.org/10.1155/2014/451042.
- Nakatani S. Left ventricular rotation and twist: why should we learn? J Cardiovasc Ultrasound. 2011 Mar;19(1):1–6. doi:https://doi.org/10.4250/jcu.2011.19.1.1.
- Hoffman JIE. Will the real ventricular architecture please stand up? Physiol Rep. 2017;5(18):e13404. doi:https://doi.org/10.14814/phy2.13404.
- Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J. 2016;37(15):1196–207. doi:https://doi.org/10.1093/eurheartj/ehv529.
- Leader CJ, Moharram M1, Coffey S, Sammut IA, Wilkins GW, Walker RJ. Myocardial global longitudinal strain: an early indicator of cardiac interstitial fibrosis modified by spironolactone, in a unique hypertensive rat model. PLoS One. 2019;14(8):e0220837.
- Cheng S, Larson MG, McCabe EL, Osypiuk E, Lehman BT, Stanchev P, Aragam J, Benjamin EJ, Solomon SD, Vasan RS. Age- and sex-based reference limits and clinical correlates of myocardial strain and synchrony: the Framingham Heart Study. Circ Cardiovasc Imaging. 2013;6(5):692–99. doi:https://doi.org/10.1161/CIRCIMAGING.112.000627.
- Carluccio E, Biagioli P, Zuchi C, Bardelli G, Murrone A, Lauciello R, D’Addario S, Mengoni A, Alunni G, Ambrosio G. Fibrosis assessment by integrated backscatter and its relationship with longitudinal deformation and diastolic function in heart failure with preserved ejection fraction. Int J Cardiovasc Imaging. 2016;32(7):1071–80. doi:https://doi.org/10.1007/s10554-016-0881-5.
- Nishimura K, Okayama H, Inoue K, Saito M, Yoshii T, Hiasa G, Sumimoto T, Inaba S, Ogimoto A, Funada J, et al. Direct measurement of radial strain in the inner-half layer of the left ventricular wall in hypertensive patients. J Cardiol. 2012;59(1):64–71. doi:https://doi.org/10.1016/j.jjcc.2011.08.003.
- Tadic M, Pieske-Kraigher E, Cuspidi C, Genger M, Morris DA, Zhang K, Walther NA, Pieske B. Left ventricular strain and twisting in heart failure with preserved ejection fraction: an updated review. Heart Fail Rev. 2017;22(3):371–79.
- Liu LS, Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615.
- Yoo JK, Okada Y, Best SA, Parker RS, Hieda M, Levine BD, Fu Q. Left ventricular remodeling and arterial afterload in older women with uncontrolled and controlled hypertension. Menopause. 2018;25(5):554–62. doi:https://doi.org/10.1097/GME.0000000000001046.
- Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, et al. American Heart Association, American College of Cardiology, and American Society of Hypertension. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation. 2015;131(19):e435–70.
- Smiseth OA. Evaluation of left ventricular diastolic function: state of the art after 35 years with Doppler assessment. J Echocardiogr. 2018;16(2):55–64. doi:https://doi.org/10.1007/s12574-017-0364-2.
- Buddhe S, Richmond ME, Gilbreth J, Lai W. Longitudinal strain by speckle tracking echocardiography in pediatric heart transplant recipients. Congenit Heart Dis. 2015;10(4):362–70. doi:https://doi.org/10.1111/chd.12263.
- Galderisi M, Lomoriello VS, Santoro A, Esposito R, Olibet M, Raia R, Di Minno MN, Guerra G, Mele D, Lombardi G. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. J Am Soc Echocardiogr. 2010;23(11):1190–98. doi:https://doi.org/10.1016/j.echo.2010.07.010.
- Uzie Bło-Życzkowska B, Krzesinński P, Witek P, Zielinński G, Jurek A, Gielerak G, Skrobowski A. Cushing’s disease: subclinical left ventricular systolic and diastolic dysfunction revealed by speckle tracking echocardiography and tissue doppler imaging. Front Endocrinol (Lausanne). 2017;8:222. doi:https://doi.org/10.3389/fendo.2017.00222.
- Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P, Tubau J. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol. 1984;53(1):120–26. doi:https://doi.org/10.1016/0002-9149(84)90695-7.
- Motoki H, Koyama J, Izawa A, Tomita T, Miyashita Y, Takahashi M, Ikeda U. Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy. Echocardiography. 2014;31(10):1230–38. doi:https://doi.org/10.1111/echo.12548.
- Pavlopoulos H, Grapsa J, Stefanadi E, Philippou E, Dawson D, Nihoyannopoulos P. Is it only diastolic dysfunction? Segmental relaxation patterns and longitudinal systolic deformation in systemic hypertension. Eur J Echocardiogr. 2008;9(6):741–47. doi:https://doi.org/10.1093/ejechocard/jen133.
- Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, et al., VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363(9426):2022–31. doi:https://doi.org/10.1016/S0140-6736(04)16451-9.
- Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, Wu KD, Tu YK, Chien KL. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis. BMJ. 2013;347(oct24 2):f6008. doi:https://doi.org/10.1136/bmj.f6008.
- Rochlani Y, Khan MH, Banach M, Aronow WS. Are two drugs better than one? A review of combination therapies for hypertension. Expert Opin Pharmacother. 2017;18(4):377–86. doi:https://doi.org/10.1080/14656566.2017.1288719.
- Frishman WH, Hainer JW, Sugg J, M-FACT Study Group. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT). Am J Hypertens. 2006;19(4):388–95. doi:https://doi.org/10.1016/j.amjhyper.2005.10.007.